Tech
Hegseth’s dubious low-T screening may flag up to 25 percent of the Army
Publication: Ars Technica - All content
Author: Beth Mole
Source published: 15/10/2026, 21:09:57 UTC
Briefing created: 15/10/2026, 22:31:23 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 15/10/2026, 21:58:24 UTC.
Briefings
A JAMA study published in October 2026 suggests up to 25% of active-duty Army members could receive low testosterone results from mandatory screening, despite the condition's true prevalence being a tiny fraction. This finding contradicts medical recommendations from the Endocrine Society and AUA against blanket screenings, potentially leading to unnecessary evaluations, inaccurate diagnoses, and harm such as infertility. The Pentagon has moved forward with plans despite expert warnings, releasing clinical guidance in September. The study highlights why symptoms are not measured and offers a glimpse of the potential scale of the issue, though the exact number of affected members remains uncertain.
Key points
- A JAMA study published in October 2026 estimates up to 25% of active-duty Army members could receive low testosterone results from mandatory screening, contradicting medical recommendations against blanket screenings.
- The Pentagon has moved forward with plans despite expert warnings from the Endocrine Society and AUA, releasing clinical guidance in September.
Context and limitations
The study highlights reasons why symptoms are not measured and offers a glimpse of the potential scale of the issue, though the exact number of affected members remains uncertain.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 15/10/2026, 22:31:23 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeih5pqapy2jsym4jmrnchg25zb7qm2al4odukfhxc3klrnpzyhelru